Literature DB >> 26215926

Two Splice Variants of Y Chromosome-Located Lysine-Specific Demethylase 5D Have Distinct Function in Prostate Cancer Cell Line (DU-145).

Zohreh Jangravi1,2, Mehdi Sharif Tabar1, Mehdi Mirzaei3, Pouria Parsamatin1, Haghighat Vakilian1, Mehdi Alikhani1, Mohammad Shabani2, Paul A Haynes4, Ann K Goodchild3, Hamid Gourabi5, Hossein Baharvand6,7, Ghasem Hosseini Salekdeh1,8.   

Abstract

One of the major objectives of the Human Y Chromosome Proteome Project is to characterize sets of proteins encoded from the human Y chromosome. Lysine (K)-specific demethylase 5D (KDM5D) is located on the AZFb region of the Y chromosome and encodes a JmjC-domain-containing protein. KDM5D, the least well-documented member of the KDM5 family, is capable of demethylating di- and trimethyl H3K4. In this study, we detected two novel splice variants of KDM5D with lengths of 2650bp and 2400bp that correspond to the 100 and 80 kDa proteins in the human prostate cancer cell line, DU-145. The knockdown of two variants using the short interfering RNA (siRNA) approach increased the growth rate of prostate cancer cells and reduced cell apoptosis. To explore the proteome pattern of the cells after KDM5D downregulation, we applied a shotgun label-free quantitative proteomics approach. Of 820 proteins present in all four replicates of two treatments, the abundance of 209 proteins changed significantly in response to KDM5D suppression. Of these, there were 102 proteins observed to be less abundant and 107 more abundant in KDM5D knockdown cells compared with control cells. The results revealed that KDM5D knockdown altered the abundance of proteins involved in RNA processing, protein synthesis, apoptosis, the cell cycle, and growth and proliferation. In conjunction, these results provided new insights into the function of KDM5D and its splice variants. The proteomics data are available at PRIDE with ProteomeXchange identifier PXD000416.

Entities:  

Keywords:  Human Proteome Project; lysine (K)-specific demethylase 5D (KDM5D); short interfering RNA (siRNA); shotgun proteomics

Mesh:

Substances:

Year:  2015        PMID: 26215926     DOI: 10.1021/acs.jproteome.5b00333

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  10 in total

Review 1.  Mosaic loss of human Y chromosome: what, how and why.

Authors:  Xihan Guo; Xueqin Dai; Tao Zhou; Han Wang; Juan Ni; Jinglun Xue; Xu Wang
Journal:  Hum Genet       Date:  2020-02-04       Impact factor: 4.132

2.  Y Chromosome Genes May Play Roles in the Development of Neural Rosettes from Human Embryonic Stem Cells.

Authors:  Farzaneh Khani; Simin Nafian; Sepideh Mollamohammadi; Shiva Nemati; Bahare Shokoohian; Seyedeh Nafiseh Hassani; Hossein Baharvand; Hamid Reza Soleimanpour-Lichaei; Ghasem Hosseini Salekdeh
Journal:  Stem Cell Rev Rep       Date:  2022-06-03       Impact factor: 5.739

Review 3.  Prostate cancer susceptibility and growth linked to Y chromosome genes.

Authors:  Riddhi Patel; Ahmad O Khalifa; Ilaha Isali; Sanjeev Shukla
Journal:  Front Biosci (Elite Ed)       Date:  2018-03-01

4.  The KDM5 family is required for activation of pro-proliferative cell cycle genes during adipocyte differentiation.

Authors:  Ann-Sofie B Brier; Anne Loft; Jesper G S Madsen; Thomas Rosengren; Ronni Nielsen; Søren F Schmidt; Zongzhi Liu; Qin Yan; Hinrich Gronemeyer; Susanne Mandrup
Journal:  Nucleic Acids Res       Date:  2017-02-28       Impact factor: 16.971

5.  Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma.

Authors:  Madeleine Arseneault; Jean Monlong; Naveen S Vasudev; Ruhina S Laskar; Maryam Safisamghabadi; Patricia Harnden; Lars Egevad; Nazanin Nourbehesht; Pudchalaluck Panichnantakul; Ivana Holcatova; Antonin Brisuda; Vladimir Janout; Helena Kollarova; Lenka Foretova; Marie Navratilova; Dana Mates; Viorel Jinga; David Zaridze; Anush Mukeria; Pouria Jandaghi; Paul Brennan; Alvis Brazma; Jorg Tost; Ghislaine Scelo; Rosamonde E Banks; Mark Lathrop; Guillaume Bourque; Yasser Riazalhosseini
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

6.  Identification of ryuvidine as a KDM5A inhibitor.

Authors:  Eishin Mitsui; Shogo Yoshida; Yui Shinoda; Yasumasa Matsumori; Hiroshi Tsujii; Mie Tsuchida; Shuichi Wada; Makoto Hasegawa; Akihiro Ito; Koshiki Mino; Tetsuo Onuki; Minoru Yoshida; Ryuzo Sasaki; Tamio Mizukami
Journal:  Sci Rep       Date:  2019-07-09       Impact factor: 4.379

Review 7.  The emerging role of KDM5A in human cancer.

Authors:  Guan-Jun Yang; Ming-Hui Zhu; Xin-Jiang Lu; Yan-Jun Liu; Jian-Fei Lu; Chung-Hang Leung; Dik-Lung Ma; Jiong Chen
Journal:  J Hematol Oncol       Date:  2021-02-17       Impact factor: 17.388

8.  Rats exhibit age-related mosaic loss of chromosome Y.

Authors:  Alberto H Orta; Stephen J Bush; Mariana Gutiérrez-Mariscal; Susana Castro-Obregón; Lorraine Jaimes-Hoy; Ricardo Grande; Gloria Vázquez; Elisa Gorostieta-Salas; Mónica Martínez-Pacheco; Karina Díaz-Barba; Paola Cornejo-Páramo; Alejandro Sanchez-Flores; Tamas Székely; Araxi O Urrutia; Diego Cortez
Journal:  Commun Biol       Date:  2021-12-21

Review 9.  Y chromosome is moving out of sex determination shadow.

Authors:  Raheleh Heydari; Zohreh Jangravi; Samaneh Maleknia; Mehrshad Seresht-Ahmadi; Zahra Bahari; Ghasem Hosseini Salekdeh; Anna Meyfour
Journal:  Cell Biosci       Date:  2022-01-04       Impact factor: 7.133

10.  Identifying the hub genes for Duchenne muscular dystrophy and Becker muscular dystrophy by weighted correlation network analysis.

Authors:  Junjie Wang; Qin Fan; Tengbo Yu; Yingze Zhang
Journal:  BMC Genom Data       Date:  2021-12-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.